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BDNFa b s t r a c t
Depression is a major health burden associated with poor quality of life and impaired functioning.
Depression is a leading cause of disability worldwide and is associated with profound economic costs.
Depression is usually treated with antidepressant medications and psychological therapy or combination
of both. However, there are lot of limitations associated with these therapies and as a result, a number of
alternative or adjunctive therapies have been sought for. Exercise is one such option with a lot of substan-
tial supportive research. The objective of the article was to review the beneficial effects of exercise in
depression. An electronic search of literature from inception till 06/2017 highlighting the effects of exer-
cise on depression and the possible mechanistic pathways involved was conducted using PubMed/
Medline, Google scholar and Scopus and relevant articles were utilized for this review. The results of this
review confirmed the beneficial role of exercise in depression as evidenced by the improvement in the
outcomes and the various psychobiological parameters measured. Thus exercise can be considered as a
treatment option for the management of depression.
 2018 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 429
2. Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 430
3. Exercise and depression. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 430
4. Exercise and depression – Mechanistic pathways . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4314.1. Effect on neurotransmitters, neurotrophins and neurogeneration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 431
4.2. Effect on pro-inflammatory cytokines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432
4.3. Modulation of hypothalamic-pituitary-adrenal axis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432
4.4. Possible involvement of endocannabinoid system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432
4.5. Effect on growth factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4325. Summary and conclusion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432
Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 433
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4331. Introduction
Major depressive disorder (MDD) is the commonly occurring
psychiatric disorder with a life-time prevalence of 15–20% and
associated with significant morbidity, mortality and disability.1Depression is characterized by fatigue, lack of energy, loss of inter-
est in normal activities, sleep disturbances including insomnia or
excessive sleeping, feelings of sadness, tearfulness, worthlessness
or guilt etc. The patients with depression often have difficulty in
thinking, concentration, making decisions and remembering
things.2 According to WHO (World Health Organization), depres-
sion is the leading cause of disability worldwide and is a major
contributor to the overall global burden of disease. More women
are affected by depression than men.3 The overall prevalence of
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lence of depression is on the verge of increasing.5 In developing
countries, 10 to 44% suffer from depression and anxiety disorders
but the medical care is received by less than 35% of the depressed.6
The prevalence of depression in primary care varies between 15.3
and 22%, with global prevalence up to 13% and between 17 and 46%
in Saudi Arabia.7 The patients with depression are usually treated
with medication or psychotherapy or a combination of both.8
Many of the depressed people do not seek any treatment and
hence depression generally remains to be one of the most under-
treated conditions.9,10 Approximately only 12% of the people with
depression seek professional help, partly because of the stigma
associated with it.10 Only 18% to 25% of the treated depressed
patients in the United States have been reported to receive ade-
quate treatment.11 The most commonly used treatments being sec-
ond generation antidepressants.12 However, patients on
antidepressant treatments often experience adverse events and
are unable to continue with the treatment.13,14 Most of the patients
on antidepressant medications do not achieve remission after ini-
tial treatment15 and nearly one-third of the patients do not achieve
remission even after several treatment steps.16,17 The patients with
depression usually have poor compliance to the medication regi-
mens.9,18,19 The patients with depression have higher treatment-
specific stigma with antidepressant medication than for example
with herbal remedies.20 Because of all these limitations, there is
a lot of emphasis on alternative treatment options. Physical exer-
cise (PE) is one such option which has gained considerable
attention.212. Methods
An electronic search of literature from inception till 06/2017
highlighting the effects of exercise on depression and the possible
mechanistic pathways involved was conducted using PubMed/
Medline, Google scholar and Scopus and relevant articles were uti-
lized for this review. The keywords used for literature search
included depression, exercise, physical activity and mechanistic
pathways. The studies involving patients with diagnosis of depres-
sion were included and studies wherein depression was reported
as co-morbidity along with another disease were excluded. Previ-
ously published reviews were also referred to. The abstracts and
articles published in languages other than English and with incom-
plete data were excluded.3. Exercise and depression
In clinical setting, exercise interventions are defined as
‘‘planned, structured, and repetitive bodily movements done to
improve or maintain one or more components of physical fit-
ness”.22 Exercise has less side-effect and can be adapted as per
medical co-morbidities and functional status of the patient.22,23
The self esteem is also enhanced with PE.24 Exercise is associated
with less stigmatization than psychotherapy and the use of phar-
macotherapies in MDD can be reduced.25 Both aerobic and anaer-
obic (strength training) forms of exercise have been beneficial in
reducing depressive symptoms. Some of the aerobic exercise activ-
ities include walking, running and cycling or a combination of
these. A lot of trials have highlighted the beneficial role of aerobic
exercise in reducing depressive symptoms while trials highlighting
the beneficial role of resistance training are few.26,27 As a result;
exercise has been included for the treatment of MDD in the
American Psychiatric Association’s most recent treatment guide-
lines.26,28 Exercise has been shown to be beneficial as a stand-
alone29,30 as well as an augmentation treatment31–33 for MDD.
The antidepressant effects of exercise are now well confirmedand can be compared with other empirically supported treatments
in mild to moderate depression.34 A large number of studies and
reviews have highlighted the beneficial effects of exercise on
depression.8,27,29–49 The outcomes of few the reports are presented
below in brief.
In 2013, Cooney et al.34 published a Cochrane review, an update
of 2009 review by Mead et al.35 The 2013 Cochrane review con-
sisted of 39 trials of which 37 provided data for meta-analysis.
However, there were multiple sourcses of bias in many of the tri-
als; in 14 of the studies randomization was adequately concealed,
15 used intention-to-treat analyses and 12 used blinded outcome
assessors. In 35 trials which compared exercise with no treatment
or a control intervention, a moderate clinical effect was found
(standardized mean difference, SMD: 0.62, 95% CI 0.810 to
0.42). And when only 6 trials with adequate allocation conceal-
ment, intention-to-treat analysis and blinded outcome assessment
were included, the outcome was not statistically significant (SMD:
0.18, 95% CI: 0.47 to 0.11). In eight of the trials providing long-
term follow-up (FU) data on mood revealed a small effect in favour
of exercise (SMD: 0.33, 95% CI: 0.63 to 0.03). In seven trials,
the effect of exercise was compared with psychological therapy
and no significant difference was noted (SMD: 0.03, 95% CI:
0.32 to 0.26). In comparison to pharmacological treatment, four
trials found no significant difference with exercise (SMD: 0.11,
95% CI: 0.34, 0.12). And one trial reported that exercise was
more effective than bright light therapy (SMD: 6.40, 95% CI:
10.20 to 2.60).
A recent study by Olson et al.45 evaluated the effect of aerobic
exercise on cognitive control in major depression (MD). The partic-
ipants were randomized to an 8-week intervention of aerobic exer-
cise (three sessions/ week of moderate-intensity exercise training)
or placebo exercise (sessions/ week of light-intensity stretching). A
significant reduction of depressive symptoms was found in aerobic
exercise group when compared with the placebo exercise group
post 8-weeks of intervention. An improvement in cognitive control
processes was also observed. However, the drawback of the study
was relatively smaller sample size (undergraduate students) and
shorter duration of intervention.
Hallgren et al.46 carried out a comparative study in 946 patients
diagnosed with mild to moderate depression who were randomly
assigned to one of three 12-week interventions: group exercise,
internet based cognitive behavioural therapy (ICBT) or treatment
as usual (TAU). In all the three groups, a significant reduction in
depression severity was observed at 12-month FU. However,
depressive symptom severity decrease was significant in exercise
and ICBT groups when compared to TAU.
Tsuji et al.47 in a prospective observational study examined the
effect of participation in group exercise and regular walking on
depressive symptoms among older survivors post the 2011 great
east Japan earthquake. The older adults who had more frequently
participated in group exercise were significantly associated with
lower depressive symptoms. Where as in older adults who did reg-
ular walking had marginally significant lower depressive
symptoms.
Blumenthal et al.48 conducted a 16-week randomized clinical
trial (RCT) to assess the effectiveness between an aerobic exercise
program and antidepressant medication (sertraline hydrochloride)
for treatment of MDD. 156 subjects were randomly assigned to a
program of aerobic exercise, antidepressant medication (sertraline
hydrochloride) or a combination of both. Post 16-weeks, aerobic
exercise and antidepressant medication were found to be equally
effective in reducing the severity of depressive symptoms, how-
ever, a faster initial response was observed with medication group
(in the first three weeks). These same subjects were examined by
Babyak et al.49 after 10 months. The results of this examination
found lower rates of depression and lower rate of relapse among
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combined groups. The subjects exercising on own during the FU
period were associated with reduced probability of depression at
the end of that period.
Chang et al.50 compared the effects of four different amounts of
exercises (3 times a week for 15 min, 3 times a week for 30 min, 6
times a week for 15 min, 6 times a week for 30 min) for preventing
depressive symptoms in community-dwelling Taiwanese older
adults (aged 65 years and above). The results of the study con-
cluded that all persistent exercise models, even if performed at
low amount (3 times a week for 15 min) had significant ameliora-
tive effects on depressive symptoms.
Roh SY.51 examined the effects of a 16-week pilates exercise
program on the ego resiliency and depression in elderly women
(n = 148). The questionnaires were used to examine the effects.
There was a statistically significant difference in self-confidence,
communication efficiency, optimistic trait and anger management.
All these sub variables of the ego resiliency of the participants
improved compared to their status before participation in the
pilates exercise program. A statistically significant difference in
depression of elderly woman was observed. The depression of
elderly woman radically decreased post exercise program than in
the preliminary test.
In a letter to the editor, Jaffery et al.52 highlighted the outcomes
of their study evaluating the effects of acute exercise (5-min bout
of walking) on depression and mood profiles using a 4-group Solo-
mon experimental design. An improvement of overall mood profile
including depression symptoms post 5-min bout of walking was
reported.
Lavretsky et al.53 conducted a RCT in elderly patients to check
the efficacy of complementary use of Tai Chi Chih (TCC) versus
health education as an addition to standard antidepressant medi-
cation treatment (escitalopram) of depression. Of the one hundred
twelve patients recruited, 73 partial responders to escitalopram
continued to receive escitalopram daily and were randomized to
receive escitalopram and TCC for 2 h per week or escitalopram
and health education for 2 h per week. A greater reduction of
depressive symptoms was noted in participants receiving escitalo-
pram with TCC when compared with those receiving escitalopram
and health education.
A recent randomized trial by Siqueira et al.54 found that in com-
parison to a no activity control group, the subjects randomized to a
4-week aerobic exercise program required a lower dosage of ser-
traline than the subjects in the control group (sertraline monother-
apy). The depression severity was significantly decreased in both
the groups post intervention.
A bunch of RCTs and meta-analyses have highlighted the bene-
fits of exercise for the management of postpartum depression. The
highlight of two of the recent meta-analyses is presented here.
Recently McCurdy et al.55 conducted a meta-analysis to exam-
ine the influence of exercise on depressive symptoms and the
prevalence of depression in the post partum period. After a rele-
vant search, 16 articles were utilized for analysis of which 10 trials
examined the effects of exercise on treatment and in six trials pre-
vention of post partum depression and depressive symptoms was
investigated. Across all the 16 trials, the pooled SMD was -0.34
(95% CI: -0.50 to -0.19), suggesting a small exercise effect on
depressive symptoms in all post partum subjects. In 10 of the
treatment trials, a moderate effect of exercise (SMD: -0.48, 95%
CI: -0.73 to -0.22) was found. In six of the prevention trials, a small
effect size of exercise (SMD: 0.22, 95% CI: 0.36 to 0.08) was
found. In women with depression, exercise was found to increase
the odds of resolving depression post intervention by 54% (odds
ratio 0.46, 95% CI: 0.25–0.84). The trials included in the meta-
analysis were of smaller size and few had methodological
limitations.Another meta-analysis by Poyatos-Leon et al.56 evaluated the
effect of physical activity (PA) interventions through pregnancy
and postpartum period for the management of postpartum depres-
sive symptoms. After a systematic and relevant search, twelve
studies were included in this meta-analysis. For PA interventions
through pregnancy and the postpartum period versus the control
group, a decrease in postpartum depressive symptoms was
observed in favour of PA group (effect size: 0.41, 95% CI: 0.28–
0.54). A post subgroup analysis, pooled effect size was 0.67 (95%
CI: 0.44–0.90) for mothers who met postpartum depressive symp-
toms criteria at baseline based on specific scales, and 0.29 (95% CI:
0.14–0.45) for mothers who did not meet those depressive symp-
toms criteria at baseline.
In a prospective interventional trial, El-Rafie et al.57 evaluated
the effect of exercise on antenatal depression. The study involved
100 pregnant women divided into exercise group and the control
group. The subjects in the exercise group had regular supervised
sessions for 12 weeks plus usual prenatal care. Post 12 week inter-
vention, a significant improvement of the depressive symptoms
was observed in exercise group when compared with the control
group. Further within groups, a significant improvement of depres-
sive symptoms from baseline to completion of intervention was
demonstrated by subjects in exercise group when compared with
the subjects in control group.4. Exercise and depression – Mechanistic pathways
The beneficial effects of exercise on depression might be
because of multiple possible mechanisms. A number of biomarkers
and parameters are altered in patients with depression. Exercise
modulates these biomarkers and parameters and results in the
improvement of depressive symptoms in the patients. The effect
of exercise on few of the biomarkers/parameters is described in
brief below.4.1. Effect on neurotransmitters, neurotrophins and neurogeneration
Exercise has shown to increase the availability of neurotrans-
mitters such as 5-HT, dopamine, and nor-adrenaline in the
brain.23,58,59 Exercise stimulates growth of nerve cells and release
of proteins which are beneficial for the health and survival of nerve
cells.37 Brain-derived neurotrophic factor (BDNF) is one such neu-
rotrophic protein has a prominent role in the neuroprotection, neu-
rogenesis, neuroregeneration and synaptic plasticity.60 The
concentration of BDNF is known to be decreased in patients with
MDD and is increased with anti-depressant drug treatment.61
BDNF serves as a growth factor for the hippocampus. Exercise
increases concentration of BDNF in patients with depression.62
There are numerous studies which have shown that exercise
enhances levels of BDNF in the hippocampus.63–65 The higher
serum levels of BDNF are associated with larger hippocampal vol-
ume.66 The hippocampal volume is reduced in patients with
depression67,68 and antidepressant treatment allows formation of
new cells in the hippocampus.69 An increase in hippocampal vol-
ume and improvement in short term memory was observed in
patients who underwent aerobic exercise for 3 months.70 In a sin-
gle blind RCT, a moderate intensity aerobic exercise intervention
carried out in older adults for one year was effective at increasing
the size of hippocampus. The volume of left and right hippocampus
was increased by 2.12% and 1.97% respectively.71 In another study,
the subjects were randomized either to a 6 week structured and
supervised exercise intervention plus TAU, or to TAU. The TAU con-
sisted to psychotherapy for each patient, plus antidepressant med-
ication. An increase in serum BDNF levels was observed in exercise
group compared to TAU group.62 Like BDNF, putative factor acting
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exercise on mood regulation is orexin-A.72,73 An increase in the
levels of orexin-A was observed in humans post exercise. The post
exercise values of orexin-A were considerably higher compared to
pre-exercise values.74
4.2. Effect on pro-inflammatory cytokines
Depression is often accompanied by activation of the inflamma-
tory response75 system as demonstrated by increased production
of pro-inflammatory cytokines (PICs) such as interleukin-1beta
(IL-1b), interleukin-2 (IL-2), interleukin-6 (IL-6), tumour necrosis
factor-alpha (TNF-a) etc.76–82 The PICs can contribute directly to
the development of depressive symptoms.83 A significantly higher
concentration of IL-6 and TNF-a has been consistently found in
depression.75 In another meta-analysis, it was confirmed that ele-
vated levels of IL-1 and IL-6 were positively associated with
depression.84 PE decreases pro-inflammatory mediators.85,86 In
105 depressed patients, a significant positive correlation between
change in IL-1b and higher baseline levels of TNF-a were associ-
ated with greater decrease in depressive symptoms following 12
weeks of aerobic exercise intervention.87 In another RCT, a
decrease in IL-6 levels was observed following a 12 week exercise
intervention. Improvements in depression severity scores were lin-
early related to reductions in serum levels of IL-6 and that higher
baseline serum IL-6 levels were associated with a stronger treat-
ment response.88 In another study, aerobic exercise over a period
of 10 months was found to reduce pro-inflammatory factors (i.e.,
C-reactive protein, interleukin-5, TNF-a and interleukin-18) when
compared to a combination of flexibility and strength exercise.89
4.3. Modulation of hypothalamic-pituitary-adrenal axis
The patients with MDD experience hyperactivity of the
hypothalamic-pituitaryadrenal (HPA) axis secondary to hyper-
secretion of corticotropin-releasing hormone (CRH). The increased
concentration of cortisol in plasma, urine and cerebrospinal fluid
(CSF) are noted in patients with depression.90 Exercise also acti-
vates the HPA axis and increases the levels of cortisol. The cortisol
serves as a mediator between chronic stress and depression and is
considered to link various cognitive deficits. The basal cortisol
levels are elevated in response to both chronic stress and exercise,
the former is detrimental to cognition, mood/stress coping, and
neural plasticity, while the latter is beneficial.91 Although acute
exercise sharply increases the levels of cortisol, chronic exercise
may also increase basal cortisol levels.92,93 In a recent review, the
authors concluded that the chronic exercise promotes structural
and functional plasticity, improve cognition and stress coping
and exert antidepressant like effects.91 In one more review, no sig-
nificant long term effects of exercise in cortisol resting levels were
found.94 Acute exercise serves as a stressor while regular exercise
initiates neuroprotective effects95 as evidenced by reduction in
response to both PE and other forms of stressor challenge.93,96 In
a study, subjects assigned to an exercise program showed reduc-
tion in the depressive scores and 24-h urinary cortisol.97 It is evi-
dent from previous studies, that antidepressant effects of
exercise might be exerted through a normalization of the HPA
axis.40,98,99 However, further research is needed in this area.
4.4. Possible involvement of endocannabinoid system
The positive effects of endocannabinoid system on depression
are well known and are partly mediated through its action on neu-
rotrophins such as BDNF. The endocannabinoid system is one of
the mechanisms involved in mediating beneficial antidepressant
effects of exercise.100 In a study involving 11 healthy trained malecyclists, exercise was found to increase the plasma levels of endo-
cannabinoids (anandamide, AEA) and BDNF. The AEA and BDNF
concentrations were positively correlated at the end of exercise
and after the 15 min recovery, suggesting the possible involvement
of AEA increment in exercise induced increase in peripheral BDNF
levels.100 Exercise is known to increase the levels of cortisol91–93
and corticosteroids are known to stimulate endocannabinoid
biosynthesis.100 An increase in the serum cortisol level was also
observed after intense exercise, which even continued during
recovery period and it was hypothesized that this increase in cor-
tisol might have stimulated the production of AEA.100
4.5. Effect on growth factors
Other possible mechanisms by which exercise might exert its
beneficial antidepressant action might be through its effects on
growth hormone (GH), insulin like growth factor-1 (IGF-1). GH
and IGF-1 are responsible for regulation of many functions of cen-
tral nervous system (CNS), including sleep, cognition, mood and
neuroprotection.101 Both GH and IGF-1 play a critical role in neural
development and regulate size, morphology and function of CNS
cells.102 Exercise stimulates GH secretion, and both aerobic and
resistance exercise result in significant acute increase in GH secre-
tion.103 After an acute bout of exercise, significant increase in GH
levels was observed among patients with MDD.104,105 A review
found that exercise promotes a moderate increase in GH in acute
studies.94 The results of a study demonstrated that peripheral
IGF-1 contributed to the antidepressant-like behavioural effect of
chronic exercise in a rodent model and a role for IGF-1 in the
antidepressant effect of exercise.106 In another rodent model, cen-
tral administration of IGF-1 was found to decrease depressive like
behaviour and was attributed to its anti-inflammatory action.107
However in one study in patients with MD, no significant changes
in IGF-1 level was found post an aerobic exercise intervention.108
5. Summary and conclusion
A lot of research has been carried out to investigate exercise as
preventative, early intervention and as a treatment option in
depression. The review highlights the beneficial effects of exercise
in depression. The review supports the role of exercise both as aug-
mentative therapy as well as stand-alone treatment and in
decreasing postpartum depressive symptoms. In patients perform-
ing regular exercise, the dose of antidepressant medication can be
lowered. The consistency is the key factor regardless of the fre-
quency or duration of exercise as long as exercise of moderate
intensity is performed.50 The exercise should be recommended
for patients with depression though of a short duration.52 The
emphasis should be given on arranging customized exercise pro-
grams keeping in mind patient’s health status and preferences
for exercise regimens thereby enhancing participation rate.109
And moreover, the exercise programs should be carried out under
the supervision of professionals with relevant training. In a recent
meta-analysis, supervised interventions were found to be linked
with larger effects. Exercise supervised by physical educators,
physiotherapists and exercise physiologists, was associated with
the greatest improvements.27 In a recent finding, the exercise
interventions delivered by exercise professionals had showed
lower dropout rates. The most common menace associated with
exercise is increased risk of musculoskeletal injury. But still in
most adults, benefits of exercise outweigh the risks. However,
exercise related risks can be reduced or avoided when exercise is
performed in consultation with well-trained professionals.22
Adverse events are remarkably rare in studies evaluating exercise
for depression. The patients should be advised to go with an agree-
able form of exercise which suits patient rather than something
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beneficial effect of exercise in depression are still not very well
understood. However, exercise is known to induce both acute
and chronic responses, particularly on hormones, neurotrophines
and inflammation biomarkers in short term.94 The main limitations
of this review is that only studies involving patients with diagnosis
of depression were included and studies wherein depression was
reported as co-morbidity along with another disease were
excluded from the review. Apart from this, there were no specific
inclusion and exclusion criterions being set. In general, the effect
of exercise on depression was reviewed with no specific emphasis
on any particular type of exercise. The article provides brief infor-
mation. Throughout the search, no specific study in Saudi popula-
tion evaluating the effects of exercise as a treatment in patients
diagnosed with depression was found. However, there were two
studies which evaluated the effect of exercise intervention on
depression scores in female university students and university
employees. But it was not evident if the participants were diag-
nosed with depression before their enrolment or had any history
of depression. The depression was one of the parameters that were
being evaluated. In both the studies, a significant improvement in
depression was noted post exercise intervention.111,112 We
strongly recommend that studies to evaluate the effect of exercise
as a treatment modality for depression should be undertaken in
Saudi population. The conclusion is that exercise should be recom-
mended for people with mild to moderate depression based on
their health status and who are motivated enough. The further
research should be carried out in a larger sample size with ade-
quate allocation concealment, using intention-to-treat analysis,
using blinded outcome assessments and concentrated on ideal fre-
quency, duration, intensity and type of exercise and identifying
and studying the mechanistic pathways.
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